Acute Coronary Syndromes Pharmacology
•Télécharger en tant que PPT, PDF•
13 j'aime•1,970 vues
![Objectives ,[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommandé
Contenu connexe
Tendances
Tendances (20)
En vedette
En vedette (20)
Similaire à Acute Coronary Syndromes Pharmacology
Similaire à Acute Coronary Syndromes Pharmacology (20)
Plus de shabeel pn
Plus de shabeel pn (20)
Dernier
Dernier (20)
Acute Coronary Syndromes Pharmacology
- 1. ACLS Pharmacology dr shabeel pn
- 10. VF / Pulseless VT Case 3
- 33. PEA Case 4
- 41. Asystole Case 5
- 49. Other Cardiac Arrest Drugs
- 56. Acute Coronary Syndromes Case 6
- 71. ST Elevation
- 73. ST Elevation Baseline Ischemia —tall or inverted T wave (infarct), ST segment may be depressed (angina) Injury —elevated ST segment, T wave may invert Infarction (Acute) —abnormal Q wave, ST segment may be elevated and T wave may be inverted Infarction (Age Unknown) —abnormal Q wave, ST segment and T wave returned to normal
- 91. PTCA
- 108. Bradycardias Case 7
- 124. Stable Tachycardias Case 9
- 159. Acute Ischemic Stroke Case 10
- 165. Drugs used in Overdoses
- 175. Review of Infusions
- 193. Questions? Jeremy Maddux [email_address]
- 195. Thank You!
Notes de l'éditeur
- Epinephrine (Class Indeterminate) 1 mg IV push every 3 to 5 minutes. If this fails, higher doses of epinephrine (up to 0.2 mg/kg) are acceptable but not recommended (there is growing evidence that it may be harmful). Vasopressin is recommended only for VF/VT; there is no evidence to support its use in asystole or PEA. There is no evidence about The value of repeated vasopressin doses or The best approach after the first single bolus of vasopressin As a Class Indeterminate action, it is acceptable to resume epinephrine 1 mg IV push every 3 to 5 minutes if there was no response in 5 to 10 minutes to a single IV dose of vasopressin. The evidence for this approach is based on rational conjecture. Suggestion to instructors Resist the requests to tell the learners whether you prefer epinephrine or vasopressin. The evidence, as of 2001, makes them equivalent, with vasopressin, as a nonadrenergic agent, associated with fewer adverse side effects. The supply chain from production to widespread distribution throughout all hospitals and the EMS system has been slow to develop.